PDA is active in the biopharmaceutical and biotechnology arena, providing education and resources on those technologies that use living cells or genetic material to treat a condition or illness (e.g., genetic disorders, tissue replacement/repair, cancer treatments), biosimilars and antibody therapeutics, and cell line maintenance and production technologies. This page presents the full variety of PDA’s offerings related to biopharmaceuticals and biotechnology, including events and training, associated interest groups, publications, and news items.